Gilead Sciences Inc (GILD)
89.71
+1.08
(+1.22%)
USD |
NASDAQ |
Nov 21, 15:34
Gilead Sciences Price to Book Value: 6.052 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 5.979 |
| November 19, 2024 | 5.920 |
| November 18, 2024 | 5.968 |
| November 15, 2024 | 5.964 |
| November 14, 2024 | 6.214 |
| November 13, 2024 | 6.249 |
| November 12, 2024 | 6.365 |
| November 11, 2024 | 6.546 |
| November 08, 2024 | 6.514 |
| November 07, 2024 | 6.604 |
| November 06, 2024 | 6.186 |
| November 05, 2024 | 6.086 |
| November 04, 2024 | 6.061 |
| November 01, 2024 | 6.038 |
| October 31, 2024 | 5.992 |
| October 30, 2024 | 5.955 |
| October 29, 2024 | 5.941 |
| October 28, 2024 | 5.986 |
| October 25, 2024 | 6.003 |
| October 24, 2024 | 5.988 |
| October 23, 2024 | 5.883 |
| October 22, 2024 | 5.946 |
| October 21, 2024 | 5.820 |
| October 18, 2024 | 5.849 |
| October 17, 2024 | 5.892 |
| Date | Value |
|---|---|
| October 16, 2024 | 5.851 |
| October 15, 2024 | 5.788 |
| October 14, 2024 | 5.736 |
| October 11, 2024 | 5.730 |
| October 10, 2024 | 5.711 |
| October 09, 2024 | 5.810 |
| October 08, 2024 | 5.747 |
| October 07, 2024 | 5.694 |
| October 04, 2024 | 5.705 |
| October 03, 2024 | 5.677 |
| October 02, 2024 | 5.715 |
| October 01, 2024 | 5.661 |
| September 30, 2024 | 5.655 |
| September 27, 2024 | 5.694 |
| September 26, 2024 | 5.655 |
| September 25, 2024 | 5.599 |
| September 24, 2024 | 5.706 |
| September 23, 2024 | 5.72 |
| September 20, 2024 | 5.717 |
| September 19, 2024 | 5.714 |
| September 18, 2024 | 5.713 |
| September 17, 2024 | 5.656 |
| September 16, 2024 | 5.664 |
| September 13, 2024 | 5.640 |
| September 12, 2024 | 5.664 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.446
Minimum
Mar 10 2022
6.604
Maximum
Nov 07 2024
4.446
Average
4.411
Median
Jul 02 2021
Price to Book Value Benchmarks
| Eli Lilly and Co | 49.78 |
| Merck & Co Inc | 5.664 |
| Pfizer Inc | 1.537 |
| Vertex Pharmaceuticals Inc | 7.414 |
| Amgen Inc | 20.72 |
Price to Book Value Related Metrics
| PE Ratio | 996.78 |
| PS Ratio | 3.968 |
| Price to Free Cash Flow | 11.91 |
| Price | 89.71 |
| Earnings Yield | 0.10% |
| Market Cap | 111.80B |
| Operating PE Ratio | 14.70 |
| Normalized PE Ratio | 20.02 |